Back to Results

CLARIVATE PLC (CLVT)

Featured in High-Beta Stocks Small-Cap Stocks

Clarivate Plc is a London-based information services company listed on the NYSE under the ticker CLVT. The company serves customers across the Americas, the Middle East, Africa, Europe, and Asia Pacific through three operating segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare. Its portfolio includes research and library solutions such as Web of Science, ProQuest, Alma, Vega, and Polaris, along with patent, trademark, and IP management tools including Derwent Innovation, Derwent World Patents Index, CompuMark, IP Recordals, RiskMark, IPfolio, and FoundationIP. Clarivate also provides life sciences and healthcare solutions through Cortellis, Regulatory Intelligence, commercial offerings, and Medtech services. The company supports academic institutions, government agencies, and pharmaceutical and broader life sciences clients. Founded in 1864 and formerly known as Clarivate Analytics Plc, it adopted its current name in May 2020.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-CLVT
$3.06
34.2% Upside
Undervalued
$2.50
9.6% Upside
Fair
Fair
—
—
—
0.0%
July 29, 2026
-10.7x
0.3x
0.6x
1.489 B
5.58 B
74.4%
73.2%
-12.6
—
-243.0%
Send a message
Valuation • Fair Value

CLARIVATE PLC (NYSE-CLVT) Fair Value by Valuation Model

Compare the primary fair value estimate for CLARIVATE PLC (NYSE-CLVT) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$3.06

Estimated upside of 34.2% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$2.64

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$3.49

Comparable-company valuation reference.

Analyst Price Target

$2.50

Analysts imply upside of 9.6%.

How to read these valuation models

Use this section to compare the primary fair value estimate for CLARIVATE PLC (NYSE-CLVT) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for CLARIVATE PLC (NYSE-CLVT)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

2.447 B

Current operating scale indicator.

Revenue Forecast

2.184 B

Forward revenue estimate.

EBITDA

932.9 M

Current operating profitability reference.

EBITDA Forecast

881.7 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review CLARIVATE PLC (NYSE-CLVT) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for CLARIVATE PLC (NYSE-CLVT)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.74

No elevated caution signal from this screen.

Altman Z-Score

-12.6

Lower score that deserves closer risk review.

FCF / Net Income

-243.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for CLARIVATE PLC (NYSE-CLVT). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for CLARIVATE PLC (NYSE-CLVT)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 29, 2026

Days to Earnings

8

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for CLARIVATE PLC (NYSE-CLVT), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

CLARIVATE PLC (NYSE-CLVT) Stock Forecast & Technical Outlook

Review CLARIVATE PLC (NYSE-CLVT) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for CLARIVATE PLC (NYSE-CLVT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for CLARIVATE PLC (NYSE-CLVT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for CLARIVATE PLC (NYSE-CLVT) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for CLARIVATE PLC (NYSE-CLVT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for CLARIVATE PLC (NYSE-CLVT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for CLARIVATE PLC (NYSE-CLVT)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, CLARIVATE PLC (NYSE-CLVT) has a Hold consensus, with 2 buy, 6 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 6
Sell 0
FAQ • Fast Investor Answers

CLARIVATE PLC (NYSE-CLVT) Stock FAQ

Quick answers about CLARIVATE PLC (NYSE-CLVT) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$3.06
Estimated upside 34.2%
Valuation Rating
Undervalued
Estimated upside of 34.2%
Analyst Target
$2.50
Implied upside 9.6%
Financial Health
Fair
Current financial-health read

The current fair value estimate for CLARIVATE PLC (NYSE-CLVT) is $3.06. This implies an estimated upside of 34.2% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 34.2% versus the current market price.

The available analyst price target for CLARIVATE PLC (NYSE-CLVT) is $2.50. The analyst target implies estimated upside of 9.6%.

The current financial health read for CLARIVATE PLC (NYSE-CLVT) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for CLARIVATE PLC (NYSE-CLVT) is July 29, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for CLARIVATE PLC (NYSE-CLVT) is -10.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for CLARIVATE PLC is 1.489 B.

The current enterprise value listed for CLARIVATE PLC is 5.58 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for CLARIVATE PLC is NYSE-CLVT, and the stock is listed on NYSE.

CLARIVATE PLC (NYSE-CLVT) is listed on NYSE.

The current debt-to-total-capital ratio listed for CLARIVATE PLC is 74.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for CLARIVATE PLC is 73.2%. Free float helps investors understand how much of the share base is available for public trading.

Similar Professional Services Stocks on NYSE View more

Relx PLC ADR (RELX) Relx PLC ADR (RELX)
Equifax Inc (EFX) Equifax Inc (EFX)
Broadridge Financial Solutions Inc (BR) Broadridge Financial Solutions Inc (BR)
UL Solutions Inc (ULS) UL Solutions Inc (ULS)
Jacobs Engineering Group Inc (J) Jacobs Engineering Group Inc (J)
TransUnion (TRU) TransUnion (TRU)
Leidos Holdings Inc (LDOS) Leidos Holdings Inc (LDOS)
CACI International Inc (CACI) CACI International Inc (CACI)
Planet Labs PBC (PL) Planet Labs PBC (PL)
Booz Allen Hamilton Holding (BAH) Booz Allen Hamilton Holding (BAH)
Paycom (PAYC) Paycom (PAYC)
Parsons Corp (PSN) Parsons Corp (PSN)
Genpact Limited (G) Genpact Limited (G)
Amentum Holdings LLC (AMTM) Amentum Holdings LLC (AMTM)
Andersen Group Corp (ANDG) Andersen Group Corp (ANDG)
FTI Consulting Inc (FCN) FTI Consulting Inc (FCN)
KBR Inc (KBR) KBR Inc (KBR)
Robert Half International Inc (RHI) Robert Half International Inc (RHI)
Korn Ferry (KFY) Korn Ferry (KFY)
Maximus Inc (MMS) Maximus Inc (MMS)
Trinet Grou (TNET) Trinet Grou (TNET)
ManpowerGroup Inc (MAN) ManpowerGroup Inc (MAN)
CBIZ Inc (CBZ) CBIZ Inc (CBZ)
Insperity Inc (NSP) Insperity Inc (NSP)